The amelioration of N-acetyl-p-benzoquinone imine toxicity by ginsenoside Rg3: The role of nrf2-mediated detoxification and mrp1/mrp3 transports

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Gum, Sang Il ^a   Cho, Min Kyung ^a  

^a Dongguk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE-CYSTEINE LIGASE; METABOLIC INTERMEDIATES; METABOLIC PROFILES; MODULATORY SUBUNITS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PROTECTIVE EFFECTS; RATE-LIMITING STEPS; TRANSCRIPTIONAL FACTORS;

AMINO ACIDS; BIOMARKERS; COORDINATION REACTIONS; DETOXIFICATION; METABOLISM; NITROGEN COMPOUNDS; POLYOLS; PROTEINS;

GENES;

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GINSENOSIDE RG 3; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE A2; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 3; N ACETYL 1,4 BENZOQUINONE IMINE; PARACETAMOL; TRANSCRIPTION FACTOR NRF2; BENZOQUINONE DERIVATIVE; GINSENOSIDE; IMINE; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 3; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 3; N ACETYL 4 BENZOQUINONEIMINE; N-ACETYL-4-BENZOQUINONEIMINE; PROTECTIVE AGENT;

ARTICLE; CATALYSIS; CELL NUCLEUS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DETOXIFICATION; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; GLUTATHIONE METABOLISM; PROTEIN FUNCTION; ANIMAL; BIOSYNTHESIS; CELL LINE; CHEMISTRY; DRUG DETOXIFICATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PROTEIN TRANSPORT; RAT;

PANAX GINSENG;

ANIMALS; BENZOQUINONES; CELL LINE; CELL NUCLEUS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GINSENOSIDES; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; IMINES; METABOLIC DETOXICATION, DRUG; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NF-E2-RELATED FACTOR 2; PROTECTIVE AGENTS; PROTEIN TRANSPORT; RATS;

EID: 84878728657     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/957947     Document Type: Article

References (39)

1. Kim S. K., Park J. H., Trends in ginseng research in 2010. Journal of Ginseng Research 2011 35 4 389 398
2. Leung K. W., Wong A. S., Pharmacology of ginsenosides: a literature review. Chinese Medicine 2010 5 article 20 2-s2.0-77953307436 10.1186/1749-8546-5-20
3. Gum S. I., Jo S. J., Ahn S. H., Kim S. G., Kim J. T., Shin H. M., Cho M. K., The potent protective effect of wild ginseng (Panax ginseng C.A. Meyer) against benzo[ α ]pyrene-induced toxicity through metabolic regulation of CYP1A1 and GSTs. Journal of Ethnopharmacology 2007 112 3 568 576 2-s2.0-34347346161 10.1016/j.jep.2007.05.014 (Pubitemid 47016888)
4. Gum S. I., Cho M. K., Korean red ginseng extract prevents APAP-induced hepatotoxicity through metabolic enzyme regulation: the role of ginsenoside Rg3, a protopanaxadiol. Liver International 2013 10.1111/liv.12046
5. Yue P. Y. K., Mak N. K., Cheng Y. K., Leung K. W., Ng T. B., Fan D. T. P., Yeung H. W., Wong R. N. S., Pharmacogenomics and the Yin/Yang actions of ginseng: anti-tumor, angiomodulating and steroid-like activities of ginsenosides. Chinese Medicine 2007 2 article 6 2-s2.0-34250887454 10.1186/1749-8546-2-6
6. Sengupta S., Toh S. A., Sellers L. A., Skepper J. N., Koolwijk P., Leung H. W., Yeung H. W., Wong R. N. S., Sasisekharan R., Fan T. P. D., Modulating angiogenesis: the yin and the yang in ginseng. Circulation 2004 110 10 1219 1225 2-s2.0-4444341635 10.1161/01.CIR.0000140676.88412.CF (Pubitemid 39202336)
7. Chen Q. J., Zhang M. Z., Wang L. X., Gensenoside Rg3 inhibits hypoxia-induced VEGF expression in human cancer cells. Cellular Physiology and Biochemistry 2010 26 6 849 858 2-s2.0-78651228186 10.1159/000323994
8. Hien T. T., Kim N. D., Pokharel Y. R., Oh S. J., Lee M. Y., Kang K. W., Ginsenoside Rg3 increases nitric oxide production via increases in phosphorylation and expression of endothelial nitric oxide synthase: essential roles of estrogen receptor-dependent PI3-kinase and AMP-activated protein kinase. Toxicology and Applied Pharmacology 2010 246 3 171 183 2-s2.0-77956886889 10.1016/j.taap.2010.05.008
9. Kim N. D., Kim E. M., Kang K. W., Cho M. K., Choi S. Y., Kim S. G., Ginsenoside Rg3 inhibits phenylephrine-induced vascular contraction through induction of nitric oxide synthase. The British Journal of Pharmacology 2003 140 4 661 670 2-s2.0-0242492625 10.1038/sj.bjp.0705490 (Pubitemid 37386430)
10. 2+ The Journal of Biological Chemistry 1985 260 24 13035 13040 2-s2.0-0022381689 (Pubitemid 16209772)
11. Enomoto A., Itoh K., Nagayoshi E., Haruta J., Kimura T., O'Connor T., Harada T., Yamamoto M., High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicological Sciences 2001 59 1 169 177 2-s2.0-0035153227 10.1093/toxsci/59.1.169 (Pubitemid 32117993)
12. Kanter M. Z., Comparison of oral and i.v. acetylcysteine in the treatment of acetaminophen poisoning. The American Journal of Health-System Pharmacy 2006 63 19 1821 1827 2-s2.0-33749169366 10.2146/ajhp060050 (Pubitemid 44477453)
13. Dawson A. H., Henry D. A., McEwen J., Adverse reactions to N-acetylcysteine during treatment for paracetamol poisoning. Medical Journal of Australia 1989 150 6 329 331 2-s2.0-0024601884 (Pubitemid 19091962)
14. Reisman S. A., Csanaky I. I., Aleksunes L. M., Klaassen C. D., Altered disposition of acetaminophen in Nrf2-null and keap1-knockdown mice. Toxicological Sciences 2009 109 1 31 40 2-s2.0-65549114152 10.1093/toxsci/kfp047
15. Yang Y., Chen Y., Johansson E., Schneider S. N., Shertzer H. G., Nebert D. W., Dalton T. P., Interaction between the catalytic and modifier subunits of glutamate-cysteine ligase. Biochemical Pharmacology 2007 74 2 372 381 2-s2.0-34250002243 10.1016/j.bcp.2007.02.003 (Pubitemid 46890809)
16. Ramos-Gomez M., Kwak M. K., Dolan P. M., Itoh K., Yamamoto M., Talalay P., Kensler T. W., Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proceedings of the National Academy of Sciences of the United States of America 2001 98 6 3410 3415 2-s2.0-0035853157 10.1073/pnas.051618798 (Pubitemid 32220859)
17. Aleksunes L. M., Slitt A. L., Maher J. M., Augustine L. M., Goedken M. J., Chan J. Y., Cherrington N. J., Klaassen C. D., Manautou J. E., Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2. Toxicology and Applied Pharmacology 2008 226 1 74 83 2-s2.0-36849088620 10.1016/j.taap.2007.08.022 (Pubitemid 350235582)
18. Maher J. M., Dieter M. Z., Aleksunes L. M., Slitt A. L., Guo G., Tanaka Y., Scheffer G. L., Chan J. Y., Manautou J. E., Chen Y., Dalton T. P., Yamamoto M., Klaassen C. D., Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway. Hepatology 2007 46 5 1597 1610 2-s2.0-36349015332 10.1002/hep.21831 (Pubitemid 350155541)
19. Villanueva S. S. M., Ruiz M. L., Ghanem C. I., Luquita M. G., Catania V. A., Mottino A. D., Hepatic synthesis and urinary elimination of acetaminophen glucuronide are exacerbated in bile duct-ligated rats. Drug Metabolism and Disposition 2008 36 3 475 480 2-s2.0-40849120695 10.1124/dmd.107.018127 (Pubitemid 351397989)
20. Ghanem C. I., Ruiz M. L., Villanueva S. S. M., Luquita M., Llesuy S., Catania V. A., Bengochea L. A., Mottino A. D., Effect of repeated administration with subtoxic doses of acetaminophen to rats on enterohepatic recirculation of a subsequent toxic dose. Biochemical Pharmacology 2009 77 10 1621 1628 2-s2.0-64049104966 10.1016/j.bcp.2009.02.006
21. Kwak M. K., Wakabayashi N., Greenlaw J. L., Yamamoto M., Kensler T. W., Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway. Molecular and Cellular Biology 2003 23 23 8786 8794 2-s2.0-0242721624 10.1128/MCB.23.23.8786-8794.2003 (Pubitemid 37433379)
22. Cho M. K., Kim W. D., Ki S. H., Hwang J. I., Choi S., Lee C. H., Kim S. G., Role of G α 12 and G α 13 as novel switches for the activity of Nrf2, a key antioxidative transcription factor. Molecular and Cellular Biology 2007 27 17 6195 6208 10.1128/MCB.02065-06 (Pubitemid 47326706)
23. Cho M. K., Kim S. G., Hepatocyte growth factor activates CCAAT enhancer binding protein and cell replication via PI3-kinase pathway. Hepatology 2003 37 3 686 695 2-s2.0-0037371283 10.1053/jhep.2003.50078 (Pubitemid 36258790)
24. Griffith O. W., Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radical Biology and Medicine 1999 27 9-10 922 935 2-s2.0-0033231162 10.1016/S0891-5849(99)00176-8 (Pubitemid 29507466)
25. Hayashi A., Suzuki H., Itoh K., Yamamoto M., Sugiyama Y., Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein 1 in mouse embryo fibroblasts. Biochemical and Biophysical Research Communications 2003 310 3 824 829 2-s2.0-0141534255 10.1016/j.bbrc.2003.09.086 (Pubitemid 37188696)
26. Poon P. Y., Kwok H. H., Yue P. Y., Yang M. S., Mak N. K., Wong C. K., Wong R. N., Cytoprotective effect of 20S-Rg3 on benzo[a]pyrene-induced DNA damage. Drug Metabolism and Disposition 2012 40 1 120 129 10.1124/dmd.111.039503
27. Cheung C., Yu A. M., Ward J. M., Krausz K. W., Akiyama T. E., Feigenbaum L., Gonzalez F. J., The CYP2E1-humanized transgenic mouse: role of CYP2E1 in acetaminophen hepatotoxicity. Drug Metabolism and Disposition 2005 33 3 449 457 2-s2.0-14044254162 10.1124/dmd.104.002402 (Pubitemid 40279947)
28. Keays R., Harrison P. M., Wendon J. A., Forbes A., Gove C., Alexander G. J. M., Williams R., Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. The British Medical Journal 1991 303 6809 1026 1029 2-s2.0-0025946778
29. Moyer A. M., Fridley B. L., Jenkins G. D., Batzler A. J., Pelleymounter L. L., Kalari K. R., Ji Y., Chai Y., Nordgren K. K. S., Weinshilboum R. M., Acetaminophen-NAPQI hepatotoxicity: a cell line model system genome-wide association study. Toxicological Sciences 2011 120 1 33 41 2-s2.0-79952081449 10.1093/toxsci/kfq375
30. Lucas A. M., Hennig G., Dominick P. K., Whiteley H. E., Roberts J. C., Cohen S. D., Ribose cysteine protects against acetaminophen-induced hepatic and renal toxicity. Toxicologic Pathology 2000 28 5 697 704 2-s2.0-0033793073
31. Goldring C. E. P., Kitteringham N. R., Elsby R., Randle L. E., Clement Y. N., Williams D. P., McMahon M., Hayes J. D., Itoh K., Yamamoto M., Park B. K., Activation of hepatic Nrf2 in vivo by acetaminophen in CD-1 mice. Hepatology 2004 39 5 1267 1276 2-s2.0-2342613543 10.1002/hep.20183 (Pubitemid 38569048)
32. Kwak M. K., Kensler T. W., Casero R. A. Jr., Induction of phase 2 enzymes by serum oxidized polyamines through activation of Nrf2: effect of the polyamine metabolite acrolein. Biochemical and Biophysical Research Communications 2003 305 3 662 670 2-s2.0-0038578527 10.1016/S0006-291X(03)00834- 9 (Pubitemid 36579282)
33. Kim S. G., Lee S. J., PI3K, RSK, and mTOR signal networks for the GST gene regulation. Toxicological Sciences 2007 96 2 206 213 2-s2.0-33947264162 10.1093/toxsci/kfl175 (Pubitemid 46432017)
34. Okada K., Shoda J., Taguchi K., Maher J. M., Ishizaki K., Inoue Y., Ohtsuki M., Goto N., Takeda K., Utsunomiya H., Oda K., Warabi E., Ishii T., Osaka K., Hyodo I., Yamamoto M., Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice. The American Journal of Physiology 2008 295 4 G735 G747 2-s2.0-57349108021 10.1152/ajpgi.90321.2008
35. Song N. Y., Kim D. H., Kim E. H., Na H. K., Kim N. J., Suh Y. G., Surh Y. J., Multidrug resistance-associated protein 1 mediates 15-deoxy-Delta(12,14)- prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells. Chemical Research in Toxicology 2011 24 8 1231 1241 10.1021/tx200090n
36. Kast H. R., Goodwin B., Tarr P. T., Jones S. A., Anisfeld A. M., Stoltz C. M., Tontonoz P., Kliewer S., Willson T. M., Edwards P. A., Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. The Journal of Biological Chemistry 2002 277 4 2908 2915 2-s2.0-0037169551 10.1074/jbc.M109326200 (Pubitemid 34953324)
37. Yamamoto T., Kyo M., Kamiya T., Tanaka T., Engel J. D., Motohashi H., Yamamoto M., Predictive base substitution rules that determine the binding and transcriptional specificity of Maf recognition elements. Genes to Cells 2006 11 6 575 591 2-s2.0-33646739904 10.1111/j.1365-2443.2006.00965.x (Pubitemid 43744809)
38. Xiong H., Turner K. C., Ward E. S., Jansen P. L. M., Brouwer K. L. R., Altered hepatobiliary disposition of acetaminophen glucuronide in isolated perfused livers from multidrug resistance-associated protein 2-deficient TR- rats1. Journal of Pharmacology and Experimental Therapeutics 2000 295 2 512 518 2-s2.0-0033776410
39. Silva V. M., Thibodeau M. S., Chen C., Manautou J. E., Transport deficient (TR-) hyperbilirubinemic rats are resistant to acetaminophen hepatotoxicity. Biochemical Pharmacology 2005 70 12 1832 1839 2-s2.0-27744567566 10.1016/j.bcp.2005.09.024 (Pubitemid 41612014)